- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives on Hypoxia Signaling in Tumor Stroma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 12, Pages 3070
Publisher
MDPI AG
Online
2021-06-21
DOI
10.3390/cancers13123070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity
- (2021) Charles W. Tran et al. PLoS One
- Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma
- (2021) Andrew J. Brenner et al. Scientific Reports
- Phase I Trial of Encapsulated Rapamycin in Prostate Cancer Patients Under Active Surveillance to Prevent Progression
- (2021) Phillip M. Kemp Bohan et al. Cancer Prevention Research
- Anti-tumor activity of NLG207 (formerly CRLX101) in combination with enzalutamide in preclinical prostate cancer models
- (2021) Keith T Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
- (2021) Victoria L. Codony et al. Translational Oncology
- Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
- (2021) Moritz J. Strowitzki et al. JCI Insight
- Metformin: A Possible Option in Cancer Chemotherapy
- (2020) Chidiebere V. Ugwueze et al. Analytical Cellular Pathology
- Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
- (2020) Ozge Saatci et al. Nature Communications
- In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
- (2020) Cameron Meaney et al. PLoS Computational Biology
- Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia
- (2020) Patricia E. de Almeida et al. Cancer Immunology Research
- Hypoxia-activated nanomedicines for effective cancer therapy
- (2020) Mengjiao Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer
- (2020) Lisa M. Becker et al. Cell Reports
- Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
- (2020) Christina S. Fjeldbo et al. EBioMedicine
- HIF-2α is indispensable for regulatory T cell function
- (2020) Tzu-Sheng Hsu et al. Nature Communications
- Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways
- (2020) Yi-Na Liu et al. Frontiers in Immunology
- The Next Wave of Stroma-Targeting Therapy in Pancreatic Cancer
- (2019) Huocong Huang et al. CANCER RESEARCH
- Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies
- (2019) Mark W. Dewhirst et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF Inhibitors: Status of Current Clinical Development
- (2019) Jaleh Fallah et al. Current Oncology Reports
- Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling
- (2019) Fernanda G. Kugeratski et al. Science Signaling
- Primary endothelial–specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia
- (2019) Rafal Bartoszewski et al. FASEB JOURNAL
- Getting a grip on adhesion: Cadherin switching and collagen signaling
- (2019) Huocong Huang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
- (2019) Najah Albadari et al. Expert Opinion on Drug Discovery
- Safety and activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrent glioblastoma (GBM).
- (2019) Roy E. Strowd et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-induced VISTA promotes the suppressive function of myeloid- derived suppressor cells in the tumor microenvironment
- (2019) Jie Deng et al. Cancer Immunology Research
- Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
- (2019) Moritz J. Strowitzki et al. PHARMACOLOGICAL RESEARCH
- miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
- (2018) Marcin Serocki et al. ANGIOGENESIS
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- A peek into cancer-associated fibroblasts: origins, functions and translational impact
- (2018) Valerie S. LeBleu et al. Disease Models & Mechanisms
- Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2αInhibitor PT2385 In Vivo and In Vitro
- (2018) Cen Xie et al. DRUG METABOLISM AND DISPOSITION
- Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models
- (2018) Sushil Kumar et al. Translational Oncology
- Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
- (2018) Adriana Albini et al. Frontiers in Immunology
- Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts
- (2018) Eibhlin Goggins et al. NEOPLASIA
- Hypoxic Signalling in Tumour Stroma
- (2018) Anu Laitala et al. Frontiers in Oncology
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
- (2018) Ivano Amelio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism
- (2017) Volker H. Haase Hemodialysis International
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
- (2017) Shujing Liu et al. Oncotarget
- Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
- (2017) Yael Gropper et al. Cell Reports
- Pharmacological HIF-inhibition attenuates postoperative adhesion formation
- (2017) Moritz J. Strowitzki et al. Scientific Reports
- The hypoxic tumor microenvironment: A driving force for breast cancer progression
- (2016) Gregg L. Semenza BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
- (2016) Francis W Hunter et al. BRITISH JOURNAL OF CANCER
- Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
- (2016) Nasim Kheshtchin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility
- (2016) Masafumi Sada et al. CANCER LETTERS
- Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer
- (2016) E. Pham et al. CANCER RESEARCH
- Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis
- (2016) L.-Y. Ye et al. CANCER RESEARCH
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- The ever-expanding role of HIF in tumour and stromal biology
- (2016) Edward L. LaGory et al. NATURE CELL BIOLOGY
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
- (2016) N. N. Rahbari et al. Science Translational Medicine
- Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
- (2016) Ines Lohse et al. Oncotarget
- Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis
- (2016) Chien-Ju Lin et al. Oncotarget
- Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR
- (2016) Xiaofan Guo et al. Oncotarget
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas
- (2015) C Yoon et al. BRITISH JOURNAL OF CANCER
- Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma
- (2015) Vasilios Liapis et al. CANCER LETTERS
- Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210
- (2015) Muhammad Zaeem Noman et al. CANCER RESEARCH
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
- (2015) S. G. J. A. Peeters et al. CLINICAL CANCER RESEARCH
- Chemotherapy Rescues Hypoxic Tumor Cells and Induces Their Reoxygenation and Repopulation--An Effect That Is Inhibited by the Hypoxia-Activated Prodrug TH-302
- (2015) J. K. Saggar et al. CLINICAL CANCER RESEARCH
- Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
- (2015) C. D. Madsen et al. EMBO REPORTS
- E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
- (2015) Jee H. Lee et al. IMMUNITY
- Cutting Edge: Hypoxia-Inducible Factor 1 Negatively Regulates Th1 Function
- (2015) Hussein Shehade et al. JOURNAL OF IMMUNOLOGY
- Minnelide, a novel drug for pancreatic and liver cancer
- (2015) Sulagna Banerjee et al. PANCREATOLOGY
- Increased expression of surface CD44 in hypoxia-DCs skews helper T cells toward a Th2 polarization
- (2015) Meixiang Yang et al. Scientific Reports
- The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts
- (2015) Anna Kuchnio et al. Cell Reports
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- HIF Transcription Factors, Inflammation, and Immunity
- (2014) Asis Palazon et al. IMMUNITY
- Short-Term Hypoxia Enhances the Migratory Capability of Dendritic Cell Through HIF-1α and PI3K/Akt Pathway
- (2014) Irene Filippi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms
- (2014) S. K. Biswas et al. JOURNAL OF IMMUNOLOGY
- Hypoxia and Hypoxia-Inducible Factor-1 Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function
- (2014) J. Jantsch et al. JOURNAL OF IMMUNOLOGY
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- Collagen Signaling Enhances Tumor Progression after Anti-VEGF Therapy in a Murine Model of Pancreatic Ductal Adenocarcinoma
- (2013) K. Y. Aguilera et al. CANCER RESEARCH
- Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression
- (2013) Daniele Pierobon et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice
- (2013) Yunching Chen et al. HEPATOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by InducingP4HA1, P4HA2,andPLOD2Expression in Fibroblasts
- (2013) Daniele M. Gilkes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- Procollagen Lysyl Hydroxylase 2 Is Essential for Hypoxia-Induced Breast Cancer Metastasis
- (2013) Daniele M. Gilkes et al. MOLECULAR CANCER RESEARCH
- BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
- (2013) B. Kutluk Cenik et al. MOLECULAR CANCER THERAPEUTICS
- Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
- (2013) Andrew L Doedens et al. NATURE IMMUNOLOGY
- Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
- (2013) S. Eliasof et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
- (2012) Cristina Branco-Price et al. CANCER CELL
- TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules
- (2012) Qian Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Loss of Fibroblast HIF-1 Accelerates Tumorigenesis
- (2012) J.-w. Kim et al. CANCER RESEARCH
- Metabolic reprogramming and two-compartment tumor metabolism
- (2012) Barbara Chiavarina et al. CELL CYCLE
- Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
- (2012) Theresa Köhler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- An N-Terminal Mutation of the Foxp3 Transcription Factor Alleviates Arthritis but Exacerbates Diabetes
- (2012) Jaime Darce et al. IMMUNITY
- Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes
- (2012) Nicolas Skuli et al. JOURNAL OF CLINICAL INVESTIGATION
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+T cells
- (2012) David K. Finlay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
- (2012) Annamaria Rapisarda et al. Nature Reviews Clinical Oncology
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
- (2012) E. T. Clambey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
- (2012) Asís Palazón et al. Cancer Discovery
- Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
- (2012) Bingxue Shang et al. Frontiers of Medicine
- Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions
- (2011) Toshitatsu Ogino et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
- (2011) Eric V. Dang et al. CELL
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide
- (2011) Antonella Naldini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Tregcells
- (2011) Lewis Z. Shi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification
- (2011) Jie Lu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo
- (2010) M. C. Bosco et al. BLOOD
- Macrophage Expression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression
- (2010) A. L. Doedens et al. CANCER RESEARCH
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Knockout of HIF-1 in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses
- (2010) C. Werno et al. CARCINOGENESIS
- Activation of fibroblasts in cancer stroma
- (2010) Kati Räsänen et al. EXPERIMENTAL CELL RESEARCH
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
- (2010) Hongxia Z. Imtiyaz et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Endothelial deletion of hypoxia-inducible factor-2 (HIF-2 ) alters vascular function and tumor angiogenesis
- (2009) N. Skuli et al. BLOOD
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Extracellular matrix genes as hypoxia-inducible targets
- (2009) Johanna Myllyharju et al. CELL AND TISSUE RESEARCH
- Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets
- (2008) Johanna Myllyharju ANNALS OF MEDICINE
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α
- (2008) Jeremy Ben-Shoshan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search